Biomarker Discovery with Spatial Resolution

Explore More

Complete Clinical Imaging Core Lab Capabilities

Learn More

Unmatched PSMA-PET Solutions: Advancing the Standard of Care

Learn More

Learn What Invicro's IQ Analytics Platform Can Do

Learn More

Gain New Insights in Early Drug Discovery

Learn More

Invicro AD/PD

Meet us at AD/PD™️ 2023

 

Join our presentations at AD/PD 2023 to gain insight into how Invicro powers CNS trials.

We are proud to showcase 2 posters and 4 oral presentations including work on Deep Super-Resolution MRI & VMAT2 PET as improved biomarkers in PD clinical trials by Dr. Brian Avants and Dr. Zhen Fan.

View Presentations

Live Webinar – Register Today!

 

Join us on April 11 at 11am ET to hear from Invicro’s Dr. Gisela Menezes Montgomery, MD, PhD, on new molecular imaging techniques in breast cancer and their potential to support personalized therapies and clinical decision-making. Grab your seat!

Register Here

SUPPORTING
ALL DRUG
DISCOVERY &
DEVELOPMENT
PHASES

DRUG
DISCOVERY EARLY
CLINICAL LATE
PHASE

THERAPEUTIC AREA EXPERTISE

ONCOLOGY

CENTRAL NERVOUS SYSTEM

RESPIRATORY

AREAS OF GROWTH

Core Capabilities

  • 3,500+ Research Trials Managed
  • 535+ Clinical Trials Managed
  • 40,000,000+ (DICOM) Images Processed
  • 800+ Molecules Labeled

CNS Webinar Series

Discover our capabilities from in vitro assays to in vivo imaging using PET, SPECT and MRI imaging biomarkers in CNS drug development and CNS clinical trials.

Watch Now

Oncology Webinar Series

Gain insights on ground-breaking techniques and imaging methods in preclinical through late-phase oncology studies.

Watch Now